ENZO—Biomol 药物筛选用样品文库

ENZO—Biomol 药物筛选用样品文库

化合物活性筛选是创新药物研究的起点和具有决定意义的步骤。离开筛选，就无从发现具有特定生物活性的新型化学物质，新药的研究开发就将成为无源之水。ENZO—Biomol提供的标准的药物筛选用样品文库，加速了您的药物筛选过程，部分产品通过FDA认证，并成为业界的金标准。

其已有产品有：

Catalog #	Name	Category
2800	BioactiveLipid Library	• CompoundLibraries
2801	EndocannabinoidLibrary	• CompoundLibraries
2803	FattyAcid Library	• CompoundLibraries
2841	FDAApproved Drug Library	• CompoundLibraries
2840	ICCBKnown Bioactives Library	• CompoundLibraries
2805	IonChannel Ligand Library	• IonChannel Reagents • CompoundLibraries
2832	KinaseInhibitor Library	• CompoundLibraries
2831	Kinase/PhosphataseInhibitor Library	• CompoundLibraries
2865	NaturalProducts Library	• CompoundLibraries
2810	NeurotransmitterLibrary	• CompoundLibraries
2802	NuclearReceptor Ligand Library	• NuclearReceptors • CompoundLibraries
2825	OrphanLigand Library	• OrphanLigands • CompoundLibraries
2834	PhosphataseInhibitor Library	• CompoundLibraries
2833	ProteaseInhibitor Library	• CompoundLibraries
2866	RareNatural Products Library	• CompoundLibraries

Many new libraries are indevelopment:

• MaxiVerse DiversityLibrary

• Failed Drugs

• Cox Inhibitors

• Approved Drugs

• Apoptosis Inducers

• Receptor Agonists

• Lipid MetabolismInhibitors

• Steroids . . . andmore

上海宝英实业有限公司地址：上海市松江区泗泾镇鼓浪路57弄16号楼501室邮编：200233
021-37789310（上海） 020-85552984(广州) E－mail:bioyinginfo@gmail.com 沪ICP备10008259号网站管理入口